Surrogate markers: The AIDS clinical trials

被引：0
|
作者：
Mildvan, D
机构：
来源：
ARCHIVES OF NEUROLOGY | 2000年 / 57卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1233 / 1234
页数：2
相关论文
共 50 条
  • [21] Surrogate Markers and Clinical Outcomes
    Richette, Pascal
    Dalbeth, Nicola
    Stamp, Lisa K.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (11):
  • [22] AIDS clinical trials
    Peto, TEA
    Babiker, AG
    Darbyshire, JH
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 1998, 10 (01): : 125 - 126
  • [23] Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosus
    Schiffenbauer, J
    Hahn, B
    Weisman, MH
    Simon, LS
    ARTHRITIS AND RHEUMATISM, 2004, 50 (08): : 2415 - 2422
  • [24] SURROGATE MARKERS FOR SURVIVAL IN PATIENTS WITH AIDS AND AIDS RELATED COMPLEX TREATED WITH ZIDOVUDINE
    JACOBSON, MA
    BACCHETTI, P
    KOLOKATHIS, A
    CHAISSON, RE
    SZABO, S
    POLSKY, B
    VALAINIS, GT
    MILDVAN, D
    ABRAMS, D
    WILBER, J
    WINGER, E
    SACKS, HS
    HENDRICKSEN, C
    MOSS, A
    BRITISH MEDICAL JOURNAL, 1991, 302 (6768): : 73 - 78
  • [25] CD4 cell count as a surrogate endpoint in HIV clinical trials: a meta-analysis of studies of the AIDS Clinical Trials Group
    Hughes, MD
    Daniels, MJ
    Fischl, MA
    Kim, S
    Schooley, RT
    AIDS, 1998, 12 (14) : 1823 - 1832
  • [26] OMARKERS AS SURROGATE ENDPOINTS IN CLINICAL TRIALS
    Rosenkranz, Bernd
    MEDICINAL CHEMISTRY RESEARCH, 2010, 19 : S31 - S32
  • [27] SURROGATE MEASURES IN CLINICAL-TRIALS
    不详
    LANCET, 1990, 335 (8684): : 261 - 262
  • [28] SURROGATE ENDPOINTS IN CLINICAL-TRIALS
    FRIEDMAN, L
    YUSUF, S
    CONTROLLED CLINICAL TRIALS, 1985, 6 (03): : 222 - 222
  • [29] Clinical trials of a stromelysin inhibitor - Osteoarthritis, matrix metalloproteinase inhibition, cartilage loss, surrogate markers, and clinical implications
    Leff, RL
    INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 : 201 - 207
  • [30] Biomarkers and surrogate endpoints in clinical trials
    Fleming, Thomas R.
    Powers, John H.
    STATISTICS IN MEDICINE, 2012, 31 (25) : 2973 - 2984
12345